Skip to main content

Table 1 Study participants and baseline characteristics

From: A randomized controlled trial of qigong for fibromyalgia

Variable Immediate practice group Wait-list, then delayed practice group
Randomized N = 53 N = 47
Completed study (%) N = 43 (81.1%) N = 30 (63.8%)
Gender M:F (% ratio) 3:50 (6:94) 1:46 (2:98)
Age at enrollment, years (SD) 52.81 (8.91) 52.13 (8.56)
Duration of FM, years (SD) 9.67 (6.87) 9.62 (7.56)
Total tender points (IQR) 15 (14, 16) 15 (13, 16)
BMI at enrollment (IQR) 30 (25.4, 34.7) 29.4 (24.8, 34.8)
Additional pain diagnoses   
Back 23 (43.3%) 21 (44.7%)
Cervical sprain 16 (30.2%) 18 (38.3%)
Diabetic neuropathy 2 (3.8%) 3 (6.4%)
Post-surgical/post-traumatic 4 (7.5%) 8 (17.0%)
Headache 31 (58.5%) 27 (57.4%)
Orofacial pain 23 (43.4%) 33 (70.2%) P < 0.007
Osteoarthritis 22 (41.5%) 17 (36.2%)
Rheumatoid arthritis 5 (9.4%) 4 (8.5%)
Other 16 (30.2%) 13 (27.7%)
Previous treatments   
Anticonvulsants 14 (26.4%) 25 (53.2%)
Antidepressants 45 (84.9%) 34 (72.3%)
Nerve blocks/injections 7 (13.2%) 4 (8.5%)
NSAIDs 37 (69.8%) 36 (76.6%)
Opioids 22 (41.5%) 14 (29.8%)
Acupuncture 24 (45.3%) 24 (51.1%)
Chiropractic 11 (20.8%) 17 (36.2%)
Naturopath/Homeopath/Osteopath 17 (32.1%) 22 (46.8%)
Massage therapy 36 (67.9%) 32 (68.1%)
Physiological therapies 26 (49.1%) 23 (48.9%)
Psychological therapies 19 (35.8%) 20 (42.6%)
Current pain medications   
Anticonvulsants 13 (24.5%) 14 (29.8%)
Antidepressants 20 (37.7%) 15 (31.9%)
NSAIDs 26 (49.1%) 27 (57.4%)
Opioids 19 (35.8%) 11 (23.4%)
Other 29 (54.7%) 28 (59.6%)
Total number (SD) 2.43 (1.41) 2.49 (1.59)
  1. BMI, body mass index; IQR, interquartile range; SD, standard deviation